Focusing on atypical symptoms for improved diagnosis of early-onset Alzheimers disease

Future Neurology

Volumn 6, Issue 5, 2011, Pages 575-578

  Lladó, Albert ^a   Sánchez Valle, Raquel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Alzheimer's disease; atypical symptoms; dementia; diagnosis; early onset

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; PRESENILIN 1; PRESENILIN 2;

ALLELE; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN GENE; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR DISORDER; BRAIN ATROPHY; COGNITIVE DEFECT; DIAGNOSTIC ERROR; EARLY ONSET ALZHEIMER DISEASE; EXECUTIVE FUNCTION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; GENOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MEMORY DISORDER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CORTICAL ATROPHY; PRESENILIN 1 GENE; PRESENILIN 2 GENE; PRIORITY JOURNAL; REVIEW; SEMANTIC DEMENTIA;

EID: 80052329725     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.11.40     Document Type: Review

References (20)

1. Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer's disease: More than age alone. J. Alzheimers Dis. 19(4), 1401-1408 (2010).
2. Van der Flier WM, Pijnenburg YA, Fox NC et al. Early-onset versus late-onset AD: The case of the missing APOE 4 allele. Lancet Neurol. 10, 280-288 (2011).
3. McKhann G, Drachman D, Folstein M, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS- ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944 (1984).
4. Balasa M, Gelpi E, Antonell A et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer's disease. Neurology 76(20), 1720-1725 (2011).
5. Stopford CL, Snowden JS, Thompson JC, Neary D. Variability in cognitive presentation of Alzheimer's disease. Cortex 44, 185-195 (2008).
6. Alladi S, Xuereb J, Bak T et al. Focal cortical presentations of Alzheimer's disease. Brain 130, 2636-2645 (2007).
7. Gorno-Tempini ML, Hillis AE et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014 (2011).
8. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123, 484-498 (2000).
9. Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol. 9, 1118-1127 (2010).
10. McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263-269 (2011).
11. Hu WT, Rippon GW, Boeve BF et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov. Disord. 24(9), 1375-1379 (2009).
12. van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 67(3), 526-527 (2006).
13. Licht EA, McMurtray AM, Saul RE, Mendez MF. Cognitive differences between early- and late-onset Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 22, 218-222 (2007).
14. Rabinovici GD, Furst AJ, Alkalay A et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133(Pt 2), 512-528 (2010).
15. Rosenbloom MH, Alkalay A, Agarwal N et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 76(21), 1789-1796 (2011).
16. Jack CR Jr., Knopman DS, Jagust WJ et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010).
17. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2, 605-613 (2003).
18. Klunk WE, Engler H, Nordberg A et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 55(3), 306-319 (2004).
19. Bouwman FH, Schoonenboom NS, Verwey NA et al. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol. Aging 30, 1895-1901 (2009).
20. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol. 6(8), 734-746 (2007).